| Advanced glycation end products (AGEs), receptor for AGEs, diabetes, and bone: review of the literature K Asadipooya, EM Uy Journal of the Endocrine Society 3 (10), 1799-1818, 2019 | 171 | 2019 |
| Transient osteoporosis of the hip: review of the literature K Asadipooya, L Graves, LW Greene Osteoporosis International 28, 1805-1816, 2017 | 116 | 2017 |
| Reduced serum osteocalcin concentrations are associated with type 2 diabetes mellitus and the metabolic syndrome components in postmenopausal women: the crosstalk between bone … A Movahed, B Larijani, I Nabipour, M Kalantarhormozi, K Asadipooya, ... Journal of bone and mineral metabolism 30, 683-691, 2012 | 100 | 2012 |
| Treatment of iron-deficiency anemia in patients with subclinical hypothyroidism M Ravanbod, K Asadipooya, M Kalantarhormozi, I Nabipour, GR Omrani The American journal of medicine 126 (5), 420-424, 2013 | 79 | 2013 |
| Secondary osteoporosis and metabolic bone diseases MM Sobh, M Abdalbary, S Elnagar, E Nagy, N Elshabrawy, M Abdelsalam, ... Journal of Clinical Medicine 11 (9), 2382, 2022 | 56 | 2022 |
| Evaluation of the incidence of sensorineural hearing loss in beta-thalassemia major patients under regular chelation therapy with desferrioxamine M Karimi, AA Asadi-Pooya, B Khademi, K Asadi-Pooya, ... Acta haematologica 108 (2), 79-83, 2002 | 50 | 2002 |
| Cardiovascular Outcomes of Romosozumab and Protective Role of Alendronate: A Conundrum or Clarification K Asadipooya, A Weinstock Arteriosclerosis, thrombosis, and vascular biology 39 (7), 1343-1350, 2019 | 43 | 2019 |
| RAGE is a potential cause of onset and progression of nonalcoholic fatty liver disease K Asadipooya, KB Lankarani, R Raj, M Kalantarhormozi International journal of endocrinology 2019, 2019 | 41 | 2019 |
| Endocrine manifestations of systemic mastocytosis in bone LW Greene, K Asadipooya, PF Corradi, C Akin Reviews in Endocrine and Metabolic Disorders 17, 419-431, 2016 | 34 | 2016 |
| Editorial: Management of osteoporosis in patients with chronic kidney disease. EHA Abdalbary M, Sobh M, Nagy E, Elnagar S, Elshabrawy N, Shemies R ... Front Med (Lausanne) 9, 1-3, 2023 | 26* | 2023 |
| Bone Quality in CKD Patients: Current Concepts and Future Directions - Part I EHA Asadipooya K, Abdalbary M, Ahmad Y, Kakani E, Monier-Faugere MC Kidney Dis (Basel) 7 ((4)), 268-27, 2021 | 22 | 2021 |
| Short-course treatment in neurobrucellosis: a study in Iran K Asadipooya, A Dehghanian, GHR Omrani, F Abbasi Neurology India 59 (1), 101-103, 2011 | 21 | 2011 |
| A randomized trial of sitagliptin and spironolactone with combination therapy in hospitalized adults with COVID-19 F Abbasi, R Adatorwovor, MA Davarpanah, Y Mansoori, M Hajiani, ... Journal of the Endocrine Society 6 (4), bvac017, 2022 | 17 | 2022 |
| Adiponectin as a protective factor against the progression toward type 2 diabetes mellitus in postmenopausal women H Darabi, A Raeisi, MR Kalantarhormozi, A Ostovar, M Assadi, ... Medicine 94 (33), e1347, 2015 | 16 | 2015 |
| Chlamydia pneumoniae and Helicobacter pylori IgG seropositivities are not predictors of osteoporosis-associated bone loss: a prospective cohort study MR Kalantarhormozi, M Assadi, K Vahdat, K Asadipooya, A Ostovar, ... Journal of bone and mineral metabolism 34, 422-428, 2016 | 15 | 2016 |
| Delusional parasitosis following heroin withdrawal: a case report A Mowla, K Asadipooya American Journal on Addictions 18 (4), 334-335, 2009 | 11 | 2009 |
| Pioglitazone reduces central obesity in polycystic ovary syndrome women K Asadipooya, M Kalantar-Hormozi, I Nabipour Gynecological Endocrinology 28 (1), 16-19, 2012 | 10 | 2012 |
| Perspective on idiopathic subchondral, osteochondral, and chondral lesions with emphasis on the knee W Fischer Seminars in Musculoskeletal Radiology 23 (05), 534-546, 2019 | 9 | 2019 |
| Delivery of euthyroid baby following hyperthyroidism in twin gestation with coexisting complete hydatidiform mole R Raj, EM Uy, M Hager, K Asadipooya Case Reports in Endocrinology 2019, 2019 | 8 | 2019 |
| Metainflammation in COVID-19 M Bakhtiari, K Asadipooya Endocr Metab Immune Disord Drug Targets, 2022 | 7 | 2022 |
